SCLXW Scilex Holding Company - Warrant
0.0880USD+40.35%Mkt Cap: —P/E: —6d ago
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical syst…
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.99BUSDP/E 14.5
$22.27BUSDP/E 30.7
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)31.61M USD
Gross Profit19.65M USD
Net Income (TTM)-358.73M USD
Revenue/Share3.64 USD
Last Price0.0880 USD
Fiscal Year End—
MR Quarter—
Employees34
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.00
EPS (TTM)—
EPS (Forward)—
52W Range
0.060019% of range0.2100
52W High0.2100 USD
52W Low0.0600 USD
Profitability
Gross Margin64.97%
Oper. Margin-385.02%
EBITDA Margin0.00%
Profit Margin-1185.78%
ROE172.65%
ROA-98.29%
Growth
Revenue Growth-22.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF3.82M USD
CapEx (TTM)733.00K USD
FCF Margin-27.98%
FCF Yield—
Net Debt105.40M USD
Net Debt/EBITDA-0.38
Balance Sheet
Debt/Equity-0.60
Current Ratio0.07
Quick Ratio0.05
Book Value/Sh-43.83 USD
Cash/Share0.08 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float5.69M
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta1.79
S&P 52W Chg15.78%
Avg Vol (30d)3.28K
Avg Vol (10d)—
Technical Indicators
RSI (14)44.5
MACD-0.0150
MACD Signal-0.0089
MACD Hist.-0.0061
BB Upper0.2197 USD
BB Middle0.1353 USD
BB Lower0.0509 USD
BB Width124.73%
ATR (14)0.0270 USD
Vol Ratio (20d)0.43x